Although a growing body of research has examined Purging Disorder (PD), there remains a lack of conclusive evidence regarding the diagnostic validity of PD. This meta-analysis compared PD to DSM-5 eating disorders (i.e., Anorexia Nervosa [AN], Bulimia Nervosa [BN], and Binge Eating Disorder [BED]) and controls. A comprehensive literature search identified 38 eligible studies. Group differences on indicators of course of illness and both general and eating psychopathology were assessed using standardized effect sizes. Results supported the conceptualization of PD as a clinically significant eating disorder, but findings were less clear regarding its distinctiveness from other eating disorder diagnoses. More specifically, PD significantly differed from BN and BED in natural course of illness (g ϭ .40 -.54), and PD significantly differed from AN in treatment outcome (g ϭ .27), with PD characterized by a better prognosis. Overall, PD was more similar to AN and BED on many dimensional measures of general and eating-related psychopathology, though PD was less severe than BN in most of these domains. PD, BN, and BED groups also evidenced similar frequencies of subjective binge episodes (SBEs), yet PD evidenced less frequent SBEs than AN. There is a clear need for future studies of PD to assess validators that have not been reported comprehensively in the literature, such as mortality, medical morbidity, and course of illness. Additionally, empirical classification studies are needed to inform future classifications of PD, particularly with regard to categorical differences between PD and other eating disorders.
With the publication of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric Association, 2013), there have been changes to the diagnostic criteria for Anorexia Nervosa (AN), Bulimia Nervosa (BN), and Binge Eating Disorder (BED), in part to address the concerning finding that most individuals presenting for eating disorder (ED) treatment did not meet diagnostic criteria for one of the primary EDs in the DSM-IV (American Psychiatric Association, 2000; Fairburn & Bohn, 2005) . Previously such individuals would have received a diagnosis of Eating Disorder Not Otherwise Specified (EDNOS), whereas the DSM-5 includes the categories of Other Specified Feeding or Eating Disorder (OSFED) and Unspecified Feeding and Eating Disorder (UFED) to account for individuals with clinically significant ED symptoms who do not meet criteria for a full-threshold ED. OSFED in particular identifies a number of specific ED symptom constellations, several of which are consistent with primary DSM-5 EDs, with certain exceptions such as limited duration (e.g., symptoms occurring for less than three months), low frequency (e.g., binge eating or purging occurring less than once per week), or atypical presentation (e.g., AN symptoms with significant weight loss, but current weight in the normal range).
One notable change to the DSM-5 was the inclusion of Purging Disorder (PD) as one specified type within OSFED. PD is characterized by recurrent purging behavior (i.e., self-induced vomiting, laxative, and/or diuretic abuse) to influence shape or weight in the absence of objective binge eating episodes (OBEs; i.e., eating an unusually large amount of food and experiencing a concurrent sense of loss of control; Keel, Haedt, & Edler, 2005) . Purging behavior is a particularly concerning clinical phenomenon in EDs, as it is associated with medical problems across body systems, including metabolic disturbances, electrolyte imbalances, edema, dental problems, esophageal tears and oral bleeding, swollen salivary glands, and musculoskeletal and gastrointestinal problems (Fairburn, 1985; Keel, 2005) . Although earlier research documented symptoms consistent with PD among individuals with eating psychopathology (Mitchell, Pyle, Hatsukami, & Eckert, 1986) , only since its formal introduction by Keel and colleagues (Keel, Mayer, & Harnden-Fischer, 2001; Keel et al., 2005) has the syndrome been the subject of more focused empirical research. The point prevalence of PD varies depending on the definition used (Crowther, Armey, Luce, Dalton, & Leahey, 2008; Haedt & Keel, 2010) , though lifetime prevalence estimates have ranged from 1.1% (Favaro, Ferrara, & Santonastaso, 2003) to 5.3% (Wade, Bergin, Tiggemann, Bulik, & Fairburn, 2006) .
To date, existing findings have generally supported the clinical significance of PD. For instance, compared with individuals without PD, those with PD exhibit higher levels of general psychopathology, distress, eating pathology, and personality disorders (Keel, Wolfe, Gravener, & Jimerson, 2008; Keel et al., 2005) . However, research has yielded mixed findings regarding how PD compares to other EDs, particularly BN. For example, some studies have demonstrated that women with PD do not significantly differ from those with BN on measures of symptom severity, impairment, body dissatisfaction, or dietary restraint (Binford & Le Grange, 2005; Keel, Mayer, & Harnden-Fischer, 2001; Keel et al., 2005) . In contrast, other literature suggests that, compared with individuals with PD, individuals with BN generally report greater eating psychopathology (Binford & Le Grange, 2005) , lower self-esteem (Binford & Le Grange, 2005) , and higher levels of general psychopathology, including mood disorders (Keel et al., 2008; Keel et al., 2005) and anxiety (Fink, Smith, Gordon, Holm-Denoma, & Joiner, 2009) . Regarding mortality, one study reported the crude mortality ratio of PD (5.0%) to be higher than both those of BN and AN purging subtypes, and the standard mortality ratio of 3.90 (95% confidence interval: 2.05, 7.21) suggested the elevated mortality risk in PD (compared with the general population) was not attributable to chance; however, it is unclear if this is a consistent finding in PD (Koch, Quadflieg, & Fitchter, 2013 . 1 Further, empirical classification studies have yielded mixed findings regarding the distinctiveness of PD, with some identifying a latent class resembling PD (Striegel-Moore et al., 2005; Sullivan, Bulik, & Kendler, 1998) , and others not consistently supporting this finding (Bulik, Sullivan, & Kendler, 2000; Keel et al., 2004; Wade, Crosby, & Martin, 2006) . Notably, there remains a dearth of information on the course, outcome, or treatment response of PD (Keel & Striegel-Moore, 2009) , as well as limited data regarding medical morbidity in PD and the degree to which purging behavior may indirectly contribute to mortality in EDs (Forney, HaedtMatt, & Keel, 2014; Keel et al., 2008) .
To date, only one meta-analysis (Thomas, Vartanian, & Brownell, 2009) has systematically compared EDNOS (now OSFED) to other ED diagnoses. Previous literature characterized EDNOS as comprising relatively heterogeneous subgroups, with the proportion of EDNOS cases resembling PD ranging from 11% (Eddy, Doyle, Hoste, Herzog, & Le Grange, 2008) to 43% (Binford & Le Grange, 2005) . However, there were few studies specifying PD as an EDNOS subtype in Thomas et al.'s (2009) analyses (k ϭ 5), and comparisons were only made between PD and BN on a limited number of outcomes. Although nosological changes reflected in the DSM-5 may have addressed some of the diagnostic issues raised by Thomas et al.'s (2009) analyses (e.g., by reducing the frequency criterion for BN and including PD as an OSFED type), the extent to which PD represents a substantial proportion of those with clinically significant ED psychopathology remains unclear and thus warrants further investigation.
Current Conceptualization for Evaluating the Validity of PD
Taken together, the mixed nature of the aforementioned evidence raises a broader issue of the diagnostic validity of PD, particularly with regard to distinctiveness from other EDs. As such, to inform future classification systems and provide a conceptualization that has clinical utility, the present investigation sought to evaluate the clinical significance and diagnostic validity of PD using a hierarchical approach and metaanalytic methodology. First, we aimed to assess the clinical significance of PD by comparing PD samples with non-ED samples on general measures of severity (i.e., mortality, medical and psychiatric morbidity, impairment, quality of life,). Second, we sought to examine the validity of categorizing PD as an ED by comparing PD to non-ED samples on measures of body dissatisfaction, restraint, and eating psychopathology. Third, we evaluated the validity of PD as a distinct ED diagnosis by making comparisons between PD and established DSM-5 diagnoses (i.e., AN, BN, BED) on measures of general and ED-related psychopathology.
The latter comparisons (i.e., between PD and other EDs) included multiple levels of evaluation. In the absence of alternative analytic approaches (e.g., taxometric or factor mixture analyses), the presence of purging and the lack of OBEs inherent in the definition of PD limits the degree to which the validity of these characteristics can be assessed as meaningful boundaries with other EDs that are defined by different symptom topographies (i.e., AN which is associated with low weight; AN-restricting type [AN-r] , which is not associated with recurrent OBEs; BN, which is associated with recurrent OBEs; and BED, which is associated with recurrent OBEs without regular purging or other compensatory behavior). However, comparing PD with other EDs on indicators of concurrent and predictive validity may provide empirical evidence to inform future clas-sification systems 2 (Kendell, 1989) . Moreover, there is evidence to suggest that EDs are more accurately categorized based upon both qualitative differences and the degree of underlying severity (Keel, Crosby, Hildebrandt, Haedt-Matt, & Gravener, 2013) .
Thus, when evaluating the validity of a diagnostic category such as PD it is important to consider both categorical differences in symptom topography and dimensional differences in severity. With the understanding that there are some qualitative differences in the topography of symptoms between PD and other EDs, we aimed to compare PD with other EDs on dimensions of severity and theoretically salient constructs to assess whether (a) PD evidences distinct course of illness compared with other EDs (i.e., predictive validity); and (b) if the level of general psychopathology and ED-related psychopathology in PD is similar to or different from full-threshold DSM-5 EDs (i.e., concurrent validity).
Predictive validity was evaluated by comparing PD with other EDs on variables related to course of illness, including mortality, age of onset, duration of illness, natural course outcome, treatment outcome, and treatment history. Consistent group differences in predictive validity would suggest that individuals PD exhibit a different trajectory of illness compared with other EDs, which may support distinctions between PD and other EDs in classification systems.
Concurrent validity was assessed by clinical features that were both non-ED and ED-related. Consistent with previous research (Keel et al., 2013) , we used non-ED indicators (i.e., medical and psychiatric morbidity, general psychopathology, suicidality, impairment, quality of life) to compare groups along a continuum of severity that may underlie all EDs but differ in degree. Indicators of psychiatric morbidity and general psychopathology included depression, anxiety, substance use, impulsivity, perfectionism, and self-esteem. Similarly, we compared PD with other EDs on dimensional measures of ED-related psychopathology (i.e., restraint, body dissatisfaction, eating psychopathology, SBE and purging frequencies) to inform how PD compares to other groups in ED symptomatology. Similarities in general and ED-related validators would suggest PD is comparable with full-threshold diagnoses in overall severity, whereas differences may indicate PD represents a distinct syndrome differing in severity.
Method

Study Selection
To obtain a comprehensive list of studies for inclusion in this meta-analysis, a literature search was conducted using the PsycINFO, PubMed, Medline, and CINAHL electronic databases. To identify potential studies, the search parameters "purging disorder," "subjective bulimia nervosa," "compensatory eating disorder," or "EDNOS-P" were entered adjacent to the terms "anorexi ‫ء‬ " 3 or "bulimi, ‫ء‬ " "binge eating disorder," or "controls" to capture the full range of terminology used to refer to AN, BN, BED, PD, and controls. To avoid potential publication biases, the Dissertation Abstracts International electronic database was also included in the search.
The resulting list of articles was separately cross-referenced with the following search parameters: "mortality," "morbidity," "comorbid ‫ء‬ ," "psychiatric," "medical," "suicid ‫ء‬ ," psychopathology," "impairment," "quality of life," "symptom, ‫ء‬ " "body dissatisfaction" or "body satisfaction," "depression," "anxiety," "selfesteem," "impuls ‫ء‬ ," "perfectionism," "treatment," "history," "outcome," "course," "age of onset," "duration," and "eating psychopathology" (or "eating disturbance"). References of the identified studies were searched to further identify studies for inclusion.
Eligibility Criteria
The following inclusion criteria were applied:
1. Only empirical studies were included so as to allow for the calculation of the standardized mean difference (i.e., effect size) of dependent variables among the subgroups.
2. Only studies that compared AN, BN, BED, or non-ED control groups with PD on the dependent variables of interest were included. Comparison groups (AN, BN, BED) that included subclinical forms were not included given that the present study aimed to examine PD in relation to full-threshold EDs as defined in DSM-5 (American Psychiatric Association, 2013).
3. Only studies written in English were included, although the country in which the data were collected was not restricted.
We contacted all authors to inquire about possible additional data that were not reported in the manuscript, when there was insufficient data to calculate necessary effect sizes, and when studies appeared to have overlapping samples; we also inquired about possible additional data that was not reported in the manuscript. Six authors provided additional data, some of which were not reported in publications. Six studies (Brown, Haedt-Matt, & Keel, 2011; Edler, Haedt, & Keel, 2007; Keel, Wolfe, Liddle, De Young, & Jimerson, 2007; Keel, Holm-Denoma, & Crosby, 2011; Stice, Marti, Shaw, & Jaconis, 2009; Wade, Fairweather-Schmidt, Zhu, & Martin, 2015) were excluded because they used the same sample as other studies that were identified (Keel et al., 2008; Keel et al., 2005; Stice, Marti, & Rohde, 2013; Wade, Bergin, Tiggemann, Bulik, & Fairburn, 2006; Wade, 2007) . Thus, 38 studies were identified for inclusion, one of which was an unpublished dissertation. Figure 1 depicts a flow diagram of the study selection process.
Data Collection
A coding form was developed to extract descriptive and quantitative information from each study (e.g., means, standard deviations, and subsample sizes; means, and exact/categorical p values; (Lipsey & Wilson, 2001) . Table 1 describes all coded comparisons, dependent variables, and moderators.
The first author screened, identified, and coded all studies, and the second author recoded all published studies. Acceptable agree-2 Evidence for etiological validity was also considered as potentially informative of diagnostic validity, but was not included in the present study because of the current lack of such research in PD samples.
3 The " ‫ء‬ " allows for the identification of terms that begin with the same stem but have multiple endings in the PsycINFO search engine. This document is copyrighted by the American Psychological Association or one of its allied publishers.
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ment was found between the two coders on categorical variables ( ϭ .90), and the percent exact agreement on quantitative variables was 95.3%. Coders resolved disagreements by discussion. To compare group means on dependent variables, effect sizes were calculated as standardized mean differences, Hedge's g, which is appropriate for use with small sample sizes (Hedges, 1981) . The values of g were interpreted such that magnitudes of 0.2, 0.5, and 0.8 represented small, medium, and large effects, respectively (Hedges, 1981) . Because meta-analysis requires independence for each study in analyses, each study could only contribute one effect size per comparison (Lipsey & Wilson, 2001 ). Thus, to adjust for dependencies among effect sizes, when studies reported data on multiple measures of the same construct (e.g., two measures of body dissatisfaction), the measures were averaged to create a composite measure that was used in effect size calculations.
Statistical Analyses
To determine the values and significance of mean effect sizes for each comparison, a random effects model was applied. A random effects model assumes that the variability is attributable to both within-study sampling error as well as random, between-study variance, that is, 2 (Hedges & Pigott, 2004; Lipsey & Wilson, 2001) . The random effects model is often preferred because it takes into account possible variations in study procedures and settings, and the resulting findings are considered to be more generalizable (Lipsey & Wilson, 2001; Rosenthal, 1995) . However, for comparisons consisting of five or fewer studies, a fixed effect model was applied (Borenstein, personal communication during workshop, 2013) . To balance the importance of reaching conclusions with the issues of statistical power (Valentine, Pigott, & Rothstein, 2010) , only comparisons that were comprised of at least three effect sizes were interpreted, though all comparisons were coded and reported in tables. The present study used both the Q statistic and the I 2 statistic to assess the heterogeneity of effect size distributions. The Q statistic has poor power to detect true heterogeneity when the meta-analysis includes a small number of studies, whereas the I 2 statistic is not dependent on the number of studies in the meta-analysis (Higgins & Thompson, 2002) . While the Q statistic assesses the statistical significance of heterogeneity, the I 2 statistic indicates the proportion of total variability in a set of effect sizes that is attributable to true betweenstudy differences (Huedo-Medina, Sánchez-Meca, Marín-Martínez, & Botella, 2006) . It has been suggested that the I 2 statistic be interpreted such that percentages of 25, 50, and 75 represent low, medium, This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
and high degrees of between-study variability, respectively. Furthermore, Fu and colleagues (2011) have advised requiring a minimum of four studies at each level to pursue analyses with categorical moderators. Therefore, if the Q and I 2 statistics together suggested substantial heterogeneity in the observed effect size distribution (as indicated by a significant Q value and I 2 statistic Ն75%), and there were at least four studies at each moderator level for which there was available data, follow-up moderator analyses were conducted to model between-study variance. That is, moderation analyses assessed whether categorical study descriptors accounted for a statistically significant proportion of the effect size variability (Lipsey & Wilson, 2001 ). In the moderator analyses, the difference between effect sizes across different levels of the moderator was assessed by computing the between-groups homogeneity statistic, Q B . Comprehensive Meta-Analysis Version 3.0 (Borenstein, Hedges, Higgins, & Rothstein, 2014) and SPSS version 24.0 were used to conduct statistical analyses.
Publication Bias
To minimize publication bias (i.e., the file drawer problem) we included both published articles and unpublished dissertations in our search process. After completing analyses, the presence of publication bias was assessed to determine whether it was likely that the publication of only significant results accounted for the observed effects. This was done by calculating the fail-safe N, which is the number of studies with a g of 0 that would bring the overall effect size to a nonsignificant level (Rosenthal, 1979) .
Results
The 38 studies ranged in year of publication from 1997 to 2016. Sample sizes ranged from 56 to 13,035 (Md ϭ 433.50, M ϭ 1,147.89, SD ϭ 2,171.21). On average, participants were 23.50 years old (SD ϭ 7.03) and had a BMI of 24.54 (SD ϭ 4.58). Samples were predominately female (M ϭ 95.6% female, SD ϭ 
PD Versus Controls
Compared with control groups, PD groups reported higher levels of suicidality, depression, anxiety, impulsivity, substance use, dietary restraint, body dissatisfaction, and eating psychopathology. Large effect sizes were observed for all comparisons with the exception of a small effect for differences in substance use. Although the comparison of suicidality yielded a marginal significance value (p ϭ .050), the effect size was large in magnitude (g ϭ 1.94) and associated with a robust fail-safe N of 583. No comparisons of mortality were available, and limited data were found for comparisons of medical morbidity, quality of life, and functional impairment. Method of diagnosis and purging frequency criteria were investigated as potential moderators of eating psychopathology comparisons, but these variables did not account for significant variability in the effect size.
PD Versus AN
PD groups evidenced a later age of onset, better treatment outcomes, and less treatment history compared with AN groups, with small to medium effects for these comparisons; conversely, PD and AN groups did not differ in duration of illness. PD groups evidenced higher levels of substance use and self-esteem, representing small and medium effects sizes, respectively. With respect to ED constructs, PD groups reported more frequent purging behavior (medium effect size), less frequent SBEs (small effect size), and higher levels of dietary restraint (small effect size). There were no significant differences in suicidality, depression, anxiety, perfectionism, eating psychopathology, or body dissatisfaction. No comparisons of PD and AN on levels of medical morbidity, quality of life, or impulsivity were available, and very few studies were found comparing AN and PD in mortality, impairment, or outcome over the natural course of illness.
PD Versus AN Moderations
Although the overall PD/AN differences in eating psychopathology and body dissatisfaction were nonsignificant, there was a high degree of variability in these effect sizes that warranted investigation of moderators. Differences in eating psychopathology and body dissatisfaction were moderated by the inclusion of SBEs in PD diagnostic criteria, such that the direction of the effect was positive (and statistically significant in the case of body dissatisfaction) when PD criteria allowed SBEs, but negative (and not significant) when SBEs were not specified. Thus, when SBEs were included in the PD diagnostic criteria, PD groups reported significantly greater body dissatisfaction than AN groups.
PD Versus BN
Compared with BN groups, PD groups evidenced a later age of onset and better outcomes over the natural course of illness, with small to medium effects; however, groups did not differ in duration of illness, treatment outcome, or treatment history. With respect to non-ED validators, PD was lower in depression (small effect), impulsivity (medium effect), and perfectionism (small to medium effect), and higher in self-esteem (small to medium effect); however, groups did not differ significantly in suicidality, substance use, or anxiety. Regarding ED-related constructs, compared with BN groups, PD groups evidenced lower frequencies of purging (small effect) and lower levels of eating psychopathology (large effect) and body dissatisfaction (small effect); group differences for restraint and SBE frequencies were nonsignificant. No comparisons of PD and BN in terms of medical morbidity were available, and limited data were found regarding mortality, quality of life, and functional impairment. Although moderators were investigated for comparisons of SBE frequency, depression, anxiety, eating psychopathology, self-esteem, and perfectionism, no moderator emerged as significant for these effects.
PD Versus BED
Compared with BED groups, PD groups evidenced a shorter duration of illness and better natural course outcome, with small to medium effect sizes, but groups did not differ in age of onset. In regards to non-ED domains, groups did not differ in suicidality, depression, anxiety, or perfectionism. In terms of ED-related domains, there were not significant group differences in SBE frequency, eating psychopathology, or body dissatisfaction, though PD groups were higher in restraint (medium effect). Comparisons of PD and BED in mortality, medical morbidity, and quality of life were unavailable, and there were insufficient data for comparisons of impairment, impulsivity, treatment outcome, treatment history, and self-esteem. Moderators were explored for PD/BED comparisons of eating psychopathology, though none emerged as significant.
Publication Bias
We investigated possible publication bias (i.e., the file drawer problem) by calculating the fail-safe N (Rosenthal, 1979) for significant overall effect sizes (see Table 3 ), which indicates the number of studies with a null effect that would render the observed overall effect nonsignificant; thus, higher values indicate more robust effects. Given the results of these calculations, it is likely that all PD/Control comparisons (fail-safe N's ranging from 102 to 1,131) are robust. Fail-safe N analyses also demonstrated robust PD/BN differences in eating psychopathology, body dissatisfaction, purging frequency, perfectionism, self-esteem, depression, impulsivity, and age of onset, with fail-safe Ns ranging from 25 to 3,585; however the difference in natural course outcome appeared less reliable (fail-safe N ϭ 10). Fail-safe N analyses for PD/AN comparisons appeared most stable for differences in age of onset, treatment history, treatment outcome, and purging frequency (fail-safe N: 18 to 59), but less so for substance use (fail-safe N ϭ 5) and restraint (fail-safe N ϭ 4), which is likely related to the small number of studies that contributed to these effects (substance use: k ϭ 4; restraint: k ϭ 5). Regarding significant PD/BED effects, the difference in duration of illness appeared more robust (fail-safe N ϭ 23) than the difference in natural course outcome (fail-safe N ϭ 11). Although there is not a clear threshold at which fail-safe N values deem effects uninterpretable because of bias, This document is copyrighted by the American Psychological Association or one of its allied publishers.
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Discussion
This meta-analysis compared PD with established DSM-5 EDs (i.e., AN, BN, BED) and non-ED controls on indicators of course of illness and severity, including both general and ED-related psychopathology. Specifically, we sought to (a) evaluate the clinical significance of PD, (b) examine the validity of its categorization as an ED, and (c) provide evidence to inform its conceptualization as a distinct ED diagnosis by assessing domains related to predictive and concurrent validity.
PD as a Clinically Significant ED
Although limited data were found on general severity indicators (i.e., mortality, medical morbidity, quality of life, impairment), results provided robust support for the clinical significance of PD, as evidenced by higher levels of suicidality and psychiatric morbidity (i.e., depression, anxiety, substance use, impulsivity) in PD compared with controls. However, the dearth of data on mortality, medical morbidity, quality of life, or impairment in PD highlights the need for future comparisons in these domains. Findings also supported the inclusion of PD in a class of psychiatric disorders that are characterized by ED psychopathology, as demonstrated by higher levels of ED-related psychopathology (i.e., eating psychopathology, restraint, body dissatisfaction) in PD compared with controls. These findings are consistent with previous research (Keel & Striegel-Moore, 2009; and extend the Note. PD ϭ Purging Disorder; AN ϭ Anorexia Nervosa; BN ϭ Bulimia Nervosa; BED ϭ Binge Eating Disorder; SBE ϭ Subjective binge episode. No studies were available at the "Excluded" level of the moderator. This document is copyrighted by the American Psychological Association or one of its allied publishers.
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This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. In addition, we reported evidence regarding the predictive validity of PD. One question that arises with respect to predictive validity is whether PD has a different trajectory of illness than the full-threshold disorders of AN, BN, and BED. Though the effect sizes were small to medium, findings suggest meaningful differences from AN regarding the trajectory or course of illness, in that AN appears to be associated with an earlier onset, more treatment history, and poorer treatment prognosis. Such findings are in line with prior research documenting low efficacy of treatment (Bulik, Berkman, Brownley, Sedway, & Lohr, 2007) and chronic course (Steinhausen, 2009 ) in AN. Thus, AN appears to represent a more pernicious ED, which is consistent with the high degree of mortality and medical complications in AN (Arcelus, Mitchell, Wales, & Nielsen, 2011; Mitchell & Crow, 2006) .
PD was associated with a better prognosis over the natural course of illness compared with BN and BED, though these effects were based on a relatively small number studies and are in need of further replication. PD groups also had a later age of onset than BN groups and a shorter duration of illness than BED. It may be that the presence of OBEs is related to a more chronic course, as studies have found that upward of 20% of BN cases demonstrate chronicity (Steinhausen & Weber, 2009) . With respect to the PD/BED comparisons, the presence of OBEs may be particularly powerful in maintaining the cycle of eating psychopathology for BED as well; furthermore, the presence of purging in PD may be experienced as comparatively more aversive, enhancing the desire to cease such behavior, and potentially contributing to the shorter duration of illness observed in PD versus BED. Interestingly, there were not significant differences between PD and BN with respect to treatment history or treatment outcome, suggesting that these groups may respond similarly to interventions targeting bulimic psychopathology.
PD Versus Other EDs: Are There Significant Differences in Severity of Non-ED and ED-Related Constructs?
This meta-analysis also addressed whether PD differed from AN, BN, and BED on various constructs related to concurrent validity, specifically general and ED-related psychopathology. Results suggested that overall and with a few exceptions, BN groups demonstrated greater severity on these dimensions. Specifically, PD groups experienced lower levels of depression, impulsivity, perfectionism, and higher levels of self-esteem than BN groups; PD groups also evidenced lower levels of eating psychopathology, body dissatisfaction, and less frequent purging. These findings could suggest that these specific domains are more severe in the presence of the OBEs that characterize BN. This is in line with a recent study of BN and PD that found the size of binge episodes explained additional variance in general and ED-related features beyond loss of control, and the relationship between loss of control eating, purging frequency, and depressive symptoms was stronger with larger binge sizes (Forney, Bodell, Haedt-Matt, & Keel, 2016) . Furthermore, given suggestions that purging behavior may function to temporarily reduce aversive affective experiences associated with binge eating , the lack of OBEs in PD may mitigate one of the primary functions of purging that serves to maintain and potentially exacerbate the behavior in other EDs characterized by OBEs.
Notably, the nonsignificant differences in restraint and SBE frequency provides evidence that individuals with PD and BN do not differ in the degree to which they attempt to restrict their intake and experience episodes of loss of control over eating normal amounts of food. A useful area for future studies would be to assess possible similarities in the antecedents and consequences of purging in PD and BN, as understanding the potential functional nature of purging in PD may further inform its conceptualization in diagnostic systems, as well as its treatment. More specifically, although PD and BN may differ in severity, as the current results suggest, there may be commonalities in the functions of their overlapping symptomatology (e.g., affect regulation).
There were far fewer significant differences between PD and AN and between PD and BED, respectively. PD groups demonstrated significantly higher levels of restraint than both AN and BED groups, though these effects were based on a small number of studies, and thus should interpreted with caution. Nevertheless, the finding that PD was higher in restraint than AN is notable in light of theoretical (Lowe, 1993; Polivy & Herman, 1985) and empirical literature (Elran-Barak et al., 2015; Stice, Davis, Miller, & Marti, 2008) documenting the relationship between restraint, dieting, and binge eating, possibly suggesting those with PD may be more predisposed to develop loss of control eating behavior than those with AN.
At the same time, though based on a limited number of studies, it is also interesting that PD groups reported more frequent purging but less frequent SBEs than AN groups. One possible explanation is that regular purging provides a sense of control over one's caloric intake, whereas those with AN who do not purge have a stronger or more frequent sense of loss of control associated with eating. However, given that there was an insufficient number of studies to assess AN subtype as a potential moderator of this effect, it is unclear how SBEs and purging in PD compare to AN-r and AN-bp (which is also characterized by purging behavior). With respect to PD/BED differences in restraint, it may be that individuals with PD are more successful in attempting to limit their intake, given the objectively large quantities of food characterizing OBEs in BED.
Implications of Moderators
Although there were insufficient data to assess many of the coded moderators, it is notable that moderations were observed in PD/AN comparisons for which overall effects were nonsignificant. When PD diagnoses allowed for the inclusion of SBEs, PD groups evidenced significantly higher body dissatisfaction and higher (albeit nonsignificant) levels of eating psychopathology than AN groups; however when the inclusion of SBEs was not specified the direction of the effect was reversed, though nonsignificant. Thus, when PD includes loss of control eating behavior, it appears there is a trend for PD to be associated with greater severity in some eating-related symptoms compared with AN. This document is copyrighted by the American Psychological Association or one of its allied publishers.
This finding is interesting in light of previous research documenting that the presence of loss of control eating is associated with impairment regardless of overeating (Forney et al., 2014; Goldschmidt et al., 2008) ; however, a recent study has suggested that PD was generally similar in psychopathology to other EDs characterized by purging (i.e., AN-bp and BN), regardless of loss of control eating (Goldschmidt et al., 2016) . Therefore, the extent to which loss of control eating or purging behavior accounts for differences in degrees of severity between PD and other EDs such as AN is unclear, and future research is needed to assess possible variations in PD/AN differences according to AN subtypes.
Clinical and Theoretical Implications
The aforementioned results regarding general and ED-related validators are clinically meaningful in that they provide information about the course of illness and degree of severity in AN, BN, and BED compared with PD. In line with the Three-Dimensional Model (Williamson, Gleaves, & Stewart, 2005) , differences in general and ED-related validators may represent variations along a continuum of psychopathology associated with EDs, though EDs may also differ categorically in some domains (e.g., the presence of OBEs). Notably, a recent factor mixture analysis of bulimic syndromes indicated a single latent severity dimension in combination with three distinct classes, but did not support clear distinctions between BN, PD, and AN-bp. Rather, the majority of PD cases were subsumed with BN and AN-bp cases in a class characterized by purging, weight phobia, and a higher level of comorbidity (Keel et al., 2013) . Taken together with the present results, PD may exist along a dimension of severity within bulimic spectrum disorders characterized by loss of control eating and purging behavior. Importantly, the qualitative differences in symptoms characterizing these ED diagnoses and the approach to examining dimensional constructs in this review preclude the ability to make any firm conclusions about categorical diagnostic differences. Thus, the varying degrees of general and ED-related severity across ED diagnoses in the present meta-analysis should be considered in conjunction with inherent qualitative differences in the topography of symptoms and clinically meaningful differences in severity of EDs, both of which are fundamental to establishing diagnostic validity.
Although the analytic approach of this meta-analysis could not evaluate possible taxonic distinctions between PD and other EDs, the present results nevertheless have clinical utility and provide information that may inform future classification research. First, it is clear that PD is a clinically significant ED that warrants intervention, though little research thus far has focused on the treatment of PD. Second, there are meaningful differences in severity indicators (i.e., predictive and concurrent validity) that could suggest there is clinical utility in distinguishing PD from other EDs. Specifically, PD was associated with a better prognosis compared with other EDs and lesser severity of symptoms compared with BN. This information may allow clinicians to more clearly conceptualize PD, and thus may provide guidance for interventions and treatment planning.
Results also highlighted the potential importance of loss of control eating (both SBEs and OBEs) and purging as possible indicators of severity as well as qualitative differences in symptomatology among EDs. Given that SBEs were evidenced by all ED groups, loss of control over eating could be a transdiagnostic symptom that varies in frequency but not in presence. Thus, SBEs may be a general indicator of severity, which has been supported by previous research (Forney et al., 2014) . This was evidenced by PD/AN moderation analyses in the present study, as well as research documenting associations between loss of control eating and indicators of general and ED-related severity (Forney et al., 2014) .
It is also notable that PD was associated with more frequent purging than AN but less than BN, which is likely related to the inclusion of both AN-r (which is not associated with purging) and AN-bp in AN comparison groups. Although the presence of regular purging behavior signifies a qualitative difference between some diagnoses (i.e., PD and BED, and PD and AN-r), the frequency of purging, like SBE frequency, may also be an indicator of severity across purging-type disorders, which is in line with previous empirical classifications (Keel et al., 2013) and findings demonstrating associations between loss of control eating and purging frequency (Forney et al., 2016) . However, because it was not possible to assess AN subtypes as moderators of differences in purging frequencies in the present study, further research is needed to compare AN-bp, PD, and BN in purging frequency and its relationship to the severity of associated symptoms.
Given the finding that BN was associated with more severe general and ED-related symptoms than PD, the presence of OBEs (i.e., the qualitatively distinct symptom in BN compared to PD) could also be conceptualized as an indicator of severity. Therefore, the binge size criterion may be important to retain in diagnostic systems to distinguish among EDs, as it appears to yield clinically useful information regarding the severity of symptomatology. Furthermore, given that the frequency of purging was higher in BN than in PD in the present study, this suggests that the combination of OBEs and more frequent purging together may signify a more severe clinical presentation. It is also notable that in previous research, larger binge size was related to more frequent purging among individuals with BN and PD who experienced relatively higher frequencies of loss of control eating, while at lower frequencies of loss of control this relationship was not observed (Forney et al., 2016) . This may seem somewhat inconsistent with the present finding that BN and PD groups did not differ in SBE frequencies, though loss of control in the previous study included both SBEs and OBEs. Thus, given that individuals with BN can experience both OBEs and SBEs, it is possible they experience relatively more frequent loss of control compared with PD, which appears to be associated with both more purging and larger binge episodes.
Limitations
The current study represents the most comprehensive metaanalysis of PD studies to date. However, although the metaanalytic approach was a particular strength of this investigation, the findings are not without limitations. There were limited data on moderators and several validators, particularly for important variables (e.g., mortality, medical morbidity) that could potentially distinguish PD from other EDs. There were not sufficient data to systematically assess the PD diagnostic criteria, which would be beneficial for future studies to explore in greater depth. There is a clear need for future research to be more explicit when defining PD, which may allow for subsequent evaluation of these criteria, particularly those proposed within the literature (e.g., see Keel & Striegel-Moore, 2009 ). It should also be noted that many of the This document is copyrighted by the American Psychological Association or one of its allied publishers.
analyses were conducted using a limited number of studies; thus, these interpretations should be made cautiously. In addition, the majority of studies included samples consisting of only Caucasian women, and therefore the present findings may not generalize to men or other ethnic groups. Although we compared PD with established DSM-5 ED diagnoses, the majority of studies reviewed were based on DSM-IV diagnoses, which raises questions as to whether diagnostic groups were consistent across studies. Furthermore, we were not able to include newly introduced DSM-5 diagnostic categories, such as Avoidant/Restrictive Food Intake Disorder, other types of OSFED (e.g., atypical AN, BN with low frequency and/or duration), or UFED.
Conclusions and Future Directions
Despite the aforementioned limitations, the present meta-analysis revealed that the literature on PD continues to grow. The present findings support PD as a clinically significant ED characterized by substantial comorbidity and severity that is on par with some fullthreshold ED diagnoses (i.e., AN and BED), but is less severe than BN in most domains. With respect to the predictive validity of PD as a diagnostic category, PD appears to be associated with a better prognosis compared with full-threshold EDs. Our findings also suggest that the frequency of SBEs could be investigated as a severity indicator across ED diagnoses, whereas purging frequency and the presence of OBEs warrant consideration as severity indicators within bulimic spectrum disorders, though further research is necessary to evaluate this conceptualization.
Notably, the differences observed between PD and other EDs in terms of severity and course of illness may have clinical utility in characterizing PD in relation to other ED diagnoses. However, given that the statistical approach of this meta-analysis precluded evaluation of categorical differences, it is yet unclear whether PD is a qualitatively distinct disorder from BN and other bulimic spectrum disorders such as AN-bp that are characterized by loss of control eating and purging behaviors, as both of these symptoms were observed in PD to varying degrees. As such, future taxometric and factor mixture analyses are needed to assess the categorical and dimensional nature of symptoms seen in PD and other EDs, particularly with respect to SBEs and purging behaviors. Doing so could inform revisions to future classification systems that account for both categorical and dimensional heterogeneity in EDs, as both of these domains are important to consider when characterizing diagnostic entities. Such classification approaches may provide clinicians with diagnostic conceptualizations that have greater clinical utility. Finally, the lack of data for many validators examined here also demonstrated a clear need for continued investigation of constructs related to course, outcome, and etiology in PD.
